| 1 |
Fiorino S, Bacchi-Reggiani L, Sabbatani S, Grizzi F, di Tommaso L, Masetti M, Fornelli A, Bondi A, de Biase D, Visani M, Cuppini A, Jovine E, Pession A. Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review. Br J Nutr 2014;112:1751-68. [PMID: 25325563 DOI: 10.1017/S0007114514002839] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 2 |
Akcam FZ, Tigli A, Kaya O, Ciris M, Vural H. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C. J Interferon Cytokine Res. 2012;32:570-574. [PMID: 23067363 DOI: 10.1089/jir.2012.0048] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 3 |
Fiorino S, Cursaro C, Lorenzini S, Loggi E, Brodosi L, Cattani L, Cuppini A, Bernardi M, Andreone P. The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. Italian Journal of Medicine 2011;5:82-89. [DOI: 10.1016/j.itjm.2011.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 4 |
Abe T, Sato M, Saigo Y, Tamai M. Interferon gamma expression and clinical features in patients with acute retinal necrosis syndrome. Graefes Arch Clin Exp Ophthalmol 2003;241:982-7. [PMID: 12928903 DOI: 10.1007/s00417-003-0725-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 5 |
Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Kashima K. The effects of prednisolone and interferons on serum macrophage colony stimulating factor concentrations in chronic hepatitis B. J Hepatol 1997;26:244-52. [PMID: 9059942 DOI: 10.1016/s0168-8278(97)80037-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Andreone P, Gramenzi A, Cursaro C, Felline F, Gasbarrini G, Bernardi M. Interaction Between Non Steroidal Antiinflammatory Drugs and Interferon-α System: Mechanisms and Basis for the Clinical Use in the Treatment of Chronic Viral Hepatitis. New Trends in Hepatology 1996. [DOI: 10.1007/978-94-009-0357-9_33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 7 |
Andreone P, Cursaro C, Gramenzi A, Buzzi A, Miniero R, Sprovieri G, Gasbarrini G. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis. J Hepatol 1994;21:984-8. [PMID: 7699263 DOI: 10.1016/s0168-8278(05)80606-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 8 |
Quiroga JA, Martin J, Pardo M, Carreño V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Dig Dis Sci 1994;39:2485-96. [PMID: 7956620 DOI: 10.1007/BF02087671] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 9 |
Katayama K, Hayashi N, Takehara T, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T. Effects of hepatitis B virus antigens on interferon-gamma production of peripheral blood mononuclear cells from hepatitis B virus carriers and healthy individuals. Scand J Gastroenterol 1994;29:849-53. [PMID: 7824867 DOI: 10.3109/00365529409092522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 10 |
Tilg H. The role of cytokines in the pathophysiology of chronic liver diseases. Int J Clin Lab Res 1993;23:179-85. [PMID: 8123873 DOI: 10.1007/BF02592306] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 11 |
Andreone P, Cursaro C, Gasbarrini G. Interferon-alpha increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon? J Hepatol 1993;19:228-31. [PMID: 8301055 DOI: 10.1016/s0168-8278(05)80576-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 12 |
Morshed SA, Fukuma H, Kimura Y, Watanabe S, Nishioka M. Interferon-gamma, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver. Gastroenterol Jpn 1993;28 Suppl 5:59-66. [PMID: 8395442 DOI: 10.1007/BF02989208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Towata T, Hayashi N, Katayama K, Takehara T, Miyoshi E, Kawanishi Y, Ueda K, Kasahara A, Fusamoto H, Kamada T. Effects of cytokines on HLA class I antigen expression on Huh6 and HB611 cells. Gastroenterol Jpn 1993;28:242-8. [PMID: 8387437 DOI: 10.1007/BF02779226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 14 |
Ishikawa T, Kakumu S, Yoshioka K, Kurokawa S, Kusakabe A, Tahara H, Hirofuji H, Kawabe M. Effects of interferon-alpha treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B. Liver 1993;13:95-101. [PMID: 8510492 DOI: 10.1111/j.1600-0676.1993.tb00613.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 15 |
Nishimura K, Ishizaka S, Tsujii T. Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitis. Biotherapy 1992;4:299-306. [PMID: 1622743 DOI: 10.1007/BF02172660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 16 |
Katayama K, Hayashi N, Takehara T, Towata T, Kasahara A, Fusamoto H, Kamada T. Effects of alpha-interferon on gamma-interferon production of peripheral blood mononuclear cells in hepatitis B virus carriers. J Clin Immunol 1992;12:347-52. [PMID: 1430105 DOI: 10.1007/BF00920792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 17 |
Takehara T, Hayashi N, Katayama K, Kasahara A, Fusamoto H, Kamada T. Hepatitis B core antigen-specific interferon gamma production of peripheral blood mononuclear cells during acute exacerbation of chronic hepatitis B. Scand J Gastroenterol 1992;27:727-31. [PMID: 1384110 DOI: 10.3109/00365529209011173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 18 |
Andreone P, Cursaro C, Gasbarrini G. Interferon-alpha therapy combined with nonsteroid antiinflammatory drugs for treatment of chronic viral hepatitis? Hepatology 1992;16:505. [PMID: 1639362 DOI: 10.1002/hep.1840160240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 19 |
Müller C, Zielinski CC. Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis. J Hepatol 1992;15:372-7. [PMID: 1447505 DOI: 10.1016/0168-8278(92)90071-v] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 20 |
Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74. [PMID: 1612333 DOI: 10.1016/0016-5085(92)91122-k] [Cited by in Crossref: 549] [Cited by in F6Publishing: 558] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 21 |
Ishikawa T, Kakumu S, Yoshioka K, Wakita T, Takayanagi M, Olido E. Immune response of peripheral blood mononuclear cells to antigenic determinants within hepatitis B core antigen in HB virus-infected man. Liver 1992;12:100-5. [PMID: 1377767 DOI: 10.1111/j.1600-0676.1992.tb00565.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 22 |
Sánchez-tapias JM. Viral Hepatitis C. In: Prieto J, Rodés J, Shafritz DA, editors. Hepatobiliary Diseases. Berlin: Springer Berlin Heidelberg; 1992. pp. 573-609. [DOI: 10.1007/978-3-642-76802-6_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 23 |
Shinagawa T, Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M. Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor alpha and interferon gamma. J Pathol 1991;165:247-53. [PMID: 1762032 DOI: 10.1002/path.1711650309] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Sylvan SP. Cellular immune responses to hepatitis B virus antigens in man. Liver 1991;11:1-23. [PMID: 1710754 DOI: 10.1111/j.1600-0676.1991.tb00485.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 25 |
Kakumu S, Yoshioka K, Wakita T, Ishikawa T. Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis. Int J Immunopharmacol 1991;13:141-6. [PMID: 1906436 DOI: 10.1016/0192-0561(91)90091-k] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 26 |
Baraldini M, Andreone P, Cursaro C, Pasini P, Verucchi G, Mazzetti M, Stefanini GF, Gasbarrini G. Role of prostaglandin E2 on defective interferon-gamma production during type B acute viral hepatitis. Ric Clin Lab 1991;21:111-7. [PMID: 1907761 DOI: 10.1007/BF02919120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 27 |
Kakumu S, Yoshioka K, Tsutsumi Y, Wakita T, Arao M. Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Clin Immunol Immunopathol 1990;56:54-65. [PMID: 2113448 DOI: 10.1016/0090-1229(90)90169-q] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 28 |
Marcellin P, Loriot MA, Boyer N, Martinot-Peignoux M, Degott C, Degos F, Brandely M, Lenfant B, Benhamou JP. Recombinant human gamma-interferon in patients with chronic active hepatitis B: pharmacokinetics, tolerance and biological effects. Hepatology 1990;12:155-8. [PMID: 2115494 DOI: 10.1002/hep.1840120124] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M, Wakita T, Ishikawa T, Mizokami M. Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease. J Clin Pathol 1990;43:298-302. [PMID: 1692847 DOI: 10.1136/jcp.43.4.298] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 30 |
Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11:628-34. [PMID: 2184115 DOI: 10.1002/hep.1840110416] [Cited by in Crossref: 143] [Cited by in F6Publishing: 144] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 31 |
Hess G. Interferone bei chronischen Virushepatitiden. Interferone 1990. [DOI: 10.1007/978-3-642-93383-7_17] [Reference Citation Analysis]
|
| 32 |
Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989;10:769-73. [PMID: 2553575 DOI: 10.1002/hep.1840100504] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 33 |
Arao M, Kakumu S, Tahara H, Yoshioka K, Sakamoto N. Interferon alpha and gamma positive mononuclear cells and HLA antigen expression on hepatocyte membrane in the liver in chronic type B and non-A, non-B hepatitis. Gastroenterol Jpn 1989;24:255-61. [PMID: 2501137 DOI: 10.1007/BF02774322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 34 |
Magrin S, Craxì A, Carini C, Colombo P, di Blasi F, Spinelli G, Fratazzi C, Messina MC, Antonelli G, Ausiello C. Interleukin-2, interleukin-2 receptor and gamma-interferon synthesis by peripheral blood mononuclear cells in chronic hepatitis delta virus infection. J Hepatol 1989;8:358-66. [PMID: 2499617 DOI: 10.1016/0168-8278(89)90035-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 35 |
Ferrari C, Penna A, DegliAntoni A, Fiaccadori F. Cellular immune response to hepatitis B virus antigens. An overview. J Hepatol 1988;7:21-33. [PMID: 3053890 DOI: 10.1016/s0168-8278(88)80503-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 36 |
Kakumu S, Fuji A, Yoshioka K, Tahara H, Ohtani Y, Hirofuji H, Murase K, Aoi T. Pilot study of recombinant human interleukin 2 for chronic type B hepatitis. Hepatology 1988;8:487-92. [PMID: 3131227 DOI: 10.1002/hep.1840080309] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
|
